BNET Industries
Last Fiscal Year Sales:$1.6B
- Private
- US
Dow Jones Description
These are such busy times, with so much going on every day, that it can be pretty tough to remember what happened even a week or two ago - let alone last year. But sometimes you do want to remember those things! What was that good Italian restaurant you went to last month? Did you call your friend on her birthday three weeks ago? Can you find the digital pictures you took on July 4th? P.Bio answers these questions for you by automatically logging key events for each day, such as who you talked to, where you bought things, and the digital pictures you took. With P.Bio you'd simply jump to the day you went out for dinner with your friend and you were at the Mona Lisa restaurant. You can go to that day your friend had her birthday (or browse the week if you're not sure of the exact day) and you'd see the call you made. Enter "7/4/2007" into your P.Bio and you'll see the pictures you took - just like that! If you like to write a diary or keep a journal, P.Bio is the perfect tool for you because knowing a single fact about a day from a week or a month ago will usually be enough to help you remember most of what happened that day. P.Bio provides those facts for you automatically. P.Bio is also a great tool for recording many other kinds of events in your life, such as dinner recipes, kids progress in school, the clothes you wore each day, and nearly anything else. ...
Chairman and Chief Executive Officer
Tony L. WhiteNumber of Employees 2,000
Contact Information
850 Lincoln Centre Dr
Foster City, California 94404-1128
(650) 570-6667
Peer Companies
NAICS Code All Other Basic Organic Chemical Manufacturing: 325199
News & Analysis
Filter by
applied biosystems group and celera genomics - All News and Analysis
Celera Genomics Reports First Quarter Fiscal 2007 Results
ROCKVILLE, Md. -- Celera Genomics Group (NYSE:CRA), an Applera Corporation business, today reported a net loss of $7.1 million, or $0.09 per share, for the first quarter of fiscal 2007 ended September 30, 2006, compared to a net loss of $16.7 million, or $0.23 per share, for the first quarter...
Laboratory Productivity Improves with First Commercial Mass Spectrometry-based System for Amino Acid Analysis
Amino Acid 20/20 Analyzer from Applied Biosystems/MDS SCIEX Brings New Approach to Common Pharmaceutical, Food Testing, and Protein Research Applications FOSTER CITY, Calif. -- Applied Biosystems (NYSE: ABI), an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc. (NYSE:MDZ, TSX:MDS), today announced a...
Applied Biosystems Group and Celera Genomics Group First Quarter Fiscal 2007 Financial Results and Conference Call Scheduled for October 25, 2006
NORWALK, Conn. -- Applera Corporation announced today that it will issue fiscal 2007 first quarter results for its Applied Biosystems Group (NYSE:ABI) and Celera Genomics Group (NYSE:CRA) on Wednesday, October 25, 2006. Results are scheduled for release before the opening of trading on the New York Stock Exchange. Tony...
Validation Study Confirms Value of TaqMan® Drug Metabolism Genotyping Assays in Pharmacogenetic and Complex Disease Research
Reference Data Made Publicly Available Through SNP500Cancer and PharmGKB Web Sites FOSTER CITY, Calif. & NEW ORLEANS -- Today at the 56th annual meeting of the American Society of Human Genetics, scientists from Applied Biosystems (NYSE:ABI), an Applera Corporation business, and SAIC-Frederick, Inc. presented data showing that the TaqMan[R]...
Advances in Genetic Analysis Technology Aid Wild Salmon Conservation and Species Management; International Researchers Convene in Alaska to Discuss How SNP Genotyping Can Further Wildlife Conservation Efforts
ANCHORAGE, Alaska & FOSTER CITY, Calif. -- Today in Anchorage, Alaska, international researchers will convene to discuss the use of the latest advances in genetic analysis technology to address the conservation and management of wild salmon in the Pacific Ocean. The conference is the second annual meeting of a multi-national...
Applied Biosystems to Webcast Its Analyst Day on September 20
FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast its Analyst Day on Wednesday, September 20. The live webcast is scheduled to begin at 9:30 a.m. ET. Tony L. White, Chief Executive Officer of Applera, will provide brief introductory remarks, after which Catherine M....
Applied Biosystems and GeneGo Collaborate to Advance Understanding of Tissue Gene Expression; GeneGo Integrates Applied Biosystems Tissue Gene Expression Database Into Its MetaCore™ Data Mining Platform
FOSTER CITY, Calif. & St. Joseph, Mich. -- Applied Biosystems (NYSE:ABI), an Applera Corporation business, and GeneGo, Inc., a leading provider of software and databases for systems biology, today announced a collaboration designed to enhance researchers' ability to study differential gene expression in biological pathways. As part of the agreement,...
Celera Genomics Reports Fourth Quarter and Fiscal 2006 Results
ROCKVILLE, Md. -- Celera Genomics Group (NYSE:CRA), an Applera Corporation business, today reported a net loss of $5.3 million, or $0.07 per share, for the fourth quarter of fiscal 2006 ended June 30, 2006, compared to a net loss of $16.4 million, or $0.22 per share, for the fourth quarter...
Applied Biosystems Innovation Enables Accurate, Quantitative Gene Expression Analysis of Very Small or Rare Samples; TaqMan® PreAmp Master Mix Kit Addresses Unmet Need to Generate Robust Real-Time PCR Results From Limited Amounts of RNA
FOSTER CITY, Calif. -- Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the launch of a commercial reagent mix that enables accurate, quantitative, real-time gene expression analysis on very small or rare samples. The TaqManR PreAmp Master Mix Kit is intended to address the challenge faced by researchers working...
Celera Receives Approval To CE Mark a New RealTime PCR HCV Genotyping Test; Highly Accurate Test Detects Major Genotypes of Hepatitis C, Further Reducing the Risk of ''Mistyping'' Errors
ROCKVILLE, Md. -- Celera Genomics (NYSE:CRA), an Applera Corporation business, today announced that a highly accurate and sensitive new test used for genotyping of the hepatitis C virus HCV has received approval to CE Mark the RealTimeTM HCV Genotype Assay, which allows it to be marketed in the European Union...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Kathy P. Ordonez | President |
| Mark O'Donnell | Division President, Global Services and Supply Chain |
| Paul S Johnson | President, Americas |
| Dennis L. Winger | Senior Vice President and Chief Financial Officer, Applera Corporation |
| Barbara J. Kerr | Senior Vice President, Human Resources |
| William B. Sawch | Senior Vice President and General Counsel, Applera Corporation |
| Claude Crawford | Vice President of Applied Biosystems' Research and Development |
| Jim Merryweather | Vice President, Strategic Planning and Business Development |
| Kim Caple | Vice President and General Manager |
| Michael G Schneider | Vice President, Worldwide Service |
| Paul D Grossman | Vice President, Intellectual Property |
| Robert Barrett | Vice President |
| Ugo D Deblasi | Vice President |
| John Bainbridge | General Manager for the Lims Business |
| Charles Purtell | Senior Director for Applied Biosystems' Consumables Business |
| Joseph Anacleto | Senior Director of Applied Biosystems' Food and Environmental Testing Group |
| Kevin McKernan | Senior Director of Scientific Operations |
| Nathan R Treff | Director of Molecular Biology, Reproductive Medicine Associates of New Jersey |
| Tamara Bond | Senior Director of Applied Biosystems' Pharmaceutical Business |
| William Craumer | Director, Investor Relations |
| Lydia Nuwaysir | Senior Product Manager |
| Mario Alberto Posada | Business Development Manager, Hispanic South America |
| Richard Fekete | Manager, Scientists, Sample Preparation R&D |
| Roger Canales | Senior Manager of Applied Biosystems' Solid Software Development Community |
| Dennis A. Gilbert | |
| Janet Ziegle | Senior Staff Scientist |
| Joel R Jung | |
| Toshihide Nishimura | |
| Norman Fogelsong | Venture Investor |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Tony L. White | Chairman and Chief Executive Officer |
| James R. Tobin | Co-Chair |
| Robert H. Hayes | Co-Chair |
| Arnold J. Levine | Board of Directors |
| Carolyn W Slayman | Board of Directors |
| Elaine Mardis | Board of Directors |
| George F Adam Jr | Board of Directors |
| Jean Luc Belingard | Board of Directors |
| Jean-Luc Belingard | Board of Directors |
| Laura Lauman | board member |
| Orin R Smith | Board of Directors |
| Philip Caldwell | Board of Directors |
| Richard H. Ayers | Board of Directors |
| Theodore E. Martin | Board of Directors |
| William H. Longfield | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Chairman and Chief Executive Officer | Current |
| Applera Corporation | Chairman, President & CEO | Current |
| Celera Genomics | Chairman, President and Chief Executive Officer | Current |
| Celera Diagnostics, LLC | Current | |
| Centenary College | Board of Directors | Current |
| Ingersoll-Rand Company Limited | Director | Current |
| C.R. Bard, Inc. | Board of Directors | Current |
| Productivity Inc. | Director | Current |
| PerkinElmer, Inc. | Chief Executive Officer | Former |
| C.R. Bard, Inc. | Chairman, President and Chief Executive Officer, Applera Corporation | Former |
| PerkinElmer, Inc. | President | Former |
| Baxter International Inc. | Executive Vice President | Former |
| AT&T Inc. | Director | Former |
| AT&T Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | President | Current |
| Celera Genomics Group | President | Current |
| Applera Corporation | Senior Vice President | Current |
| Celera Genomics | Senior Vice President, Applera and President, Celera Genomics and Celera Diagnostics | Current |
| Celera Genomics | CEO and Director | Current |
| Roche Molecular Systems, Inc. | Chief Executive Officer | Former |
| Applera Corporation | Chief Executive Officer | Former |
| Celera Genomics | President | Former |
| Applera Corporation | President | Former |
| Hoffmann-La Roche Inc. | President | Former |
| Roche Molecular Systems, Inc. | President | Former |
| Celera Genomics | President | Former |
| Celera Diagnostics, LLC | President | Former |
| Applied Biosystems Group | Senior Vice President, Applera Corporation, President, Celera Genomics and Celera Diagnostics | Former |
| Union Carbide Corporation | Former | |
| Roche | Former | |
| Applera Corporation | Chairman | Former |
| Hartwick College | Bachelor's Degree In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Division President, Global Services and Supply Chain | Current |
| Biolayer Corporation Limited | Senior Vice President, Global Operations and Services | Current |
| University Corp. | M.B.A. | Former |
| University of New Haven | Master's In Business Administration | Former |
| University of Connecticut | Bachelor's Degree In Liberal Arts | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | President, Americas | Current |
| Applied Biosystems Group | Vice President, Americas Sales | Current |
| Global Marketing Inc. | Vice President, Americas Sales | Former |
| Worcester Polytechnic Institute | Bachelor of Science In Mechanical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President and Chief Financial Officer, Applera Corporation | Current |
| Applera Corporation | Chief Financial Officer | Current |
| PerSeptive BioSystems, Inc. | CFO & Senior Vice President | Current |
| Applera Corporation | Senior Vice President | Current |
| Celera Genomics | Current | |
| Celera Diagnostics, LLC | Current | |
| Cephalon, Inc. | Board of Directors | Current |
| Cell Genesys, Inc. | Director | Current |
| Eisenhower Fellowships | Board of Directors | Current |
| Personalized Medicine Coalition | Board of Directors | Current |
| Personalized Medicine Coalition | Member | Current |
| The Cooper Companies, Inc. | Chief Financial Officer | Former |
| Chiron | Chief Financial Officer | Former |
| Chiron | Senior Vice President, Finance and Administration | Former |
| The Cooper Companies, Inc. | NA | Former |
| Chiron | Finance | Former |
| A.P. Pharma, Inc. | Board of Directors | Former |
| Columbia University | MBA In Finance | Former |
| Columbia University | Bachelor's Degree In History | Former |
| Siena College | Bachelor’S Degree In History | Former |
| Applera Corporation | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President, Human Resources | Current |
| Celera Genomics | Vice President, Human Resources | Current |
| PerSeptive BioSystems, Inc. | Vice President, HR | Current |
| Applera Corporation | Vice President, Human Resources | Current |
| Celera Diagnostics, LLC | Current | |
| Applera Corporation | Board of Directors | Current |
| Chiron | Vice President, Human Resources | Former |
| Applied Biosystems Group | Vice President, Human Resources, Applera Corporation | Former |
| Applied Biosystems Group | Human Resources Executive | Former |
| Golden Gate University | Master’S of Business Aministration | Former |
| University of Rochester | Master’S of Education | Former |
| Wittenberg University | Bachelor’S Degree In American Studies | Former |
| Applera Corporation | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Vice President and General Counsel, Applera Corporation | Current |
| Applera Corporation | Senior Vice President | Current |
| Applera Corporation | General Counsel | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Accenture Ltd. | management consultant | Former |
| Cummings & Lockwood | Attorney | Former |
| Applied Biosystems Group | Corporate Attorney | Former |
| Georgetown University Law Center | JD | Former |
| Princeton University | Bachelor of Science degree in engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President of Applied Biosystems' Research and Development | Current |
| Rensselaer Polytechnic Institute | Bachelor of Chemical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Incyte Corporation | Executive Vice President, Business Development & Commercial Operations | Current |
| Applied Biosystems Group | Vice President, Strategic Planning and Business Development | Current |
| Ciphergen Biosystems, Inc. | Executive Vice President, Pharmaceutical Corp Development | Former |
| Millennium Pharmaceuticals, Inc. | Vice President, Program Management | Former |
| Chiron | Director of Project Management | Former |
| Chiron | Senior Scientist | Former |
| The Corporate Development Company | Former | |
| Washington State University | PhD In Biochemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President and General Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President, Worldwide Service | Current |
| Applied Biosystems Group | Division President, Service | Former |
| Advanced Micro Devices, Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| Emiliem, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Industry Ventures | Senior Vice President, Strategy and Corporate Development | Current |
| Bioreliance Corporation | Senior Vice President, Strategy and Corporate Development | Current |
| Microseq | Senior Vice President, Strategy and Corporate Development | Current |
| Biolayer Corporation Limited | Senior Vice President, Strategy and Corporate Development | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Senior Vice President, Strategy and Corporate Development | Current |
| Oligoperfect | Senior Vice President, Strategy and Corporate Development | Current |
| Olink | Senior Vice President, Strategy and Corporate Development | Current |
| IDEXX Laboratories, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Seqanswers | Senior Vice President, Strategy and Corporate Development | Current |
| Ionsource, LLC | Senior Vice President, Strategy and Corporate Development | Current |
| Biosource International, Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Molecular Probes | Senior Vice President, Strategy and Corporate Development | Current |
| Resgen Inc. | Senior Vice President, Strategy and Corporate Development | Current |
| Applied Biosystems Group | Vice President, Intellectual Property | Current |
| Applied Biosystems Group | Research Associate | Former |
| Santa Clara University | JD | Former |
| University of California, Berkeley | Ph.D. in chemical engineering | Former |
| University of Virginia | master's degree in chemical engineering | Former |
| University of Virginia | B.S. | Former |
| University of California, Berkeley | B.S. | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | General Manager for the Lims Business | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Director for Applied Biosystems' Consumables Business | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Director of Applied Biosystems' Food and Environmental Testing Group | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Director of Scientific Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Director of Molecular Biology, Reproductive Medicine Associates of New Jersey | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Director of Applied Biosystems' Pharmaceutical Business | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Director, Investor Relations | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Product Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Business Development Manager, Hispanic South America | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Manager, Scientists, Sample Preparation R&D | Current |
| Ambion Inc. | Research Scientist | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Manager of Applied Biosystems' Solid Software Development Community | Current |
Prior to founding VitaPath Genetics, Dennis A. Gilbert was Chief Scientific Officer and Vice President of Research of Applied Biosystems and a Vice President of Applera Corporation. He also directed the Applied Biosystems Advanced Research and Technology (ART) organization, which was responsible for identifying and developing new technologies. Previously, Dr. Gilbert had more than ten years of senior management experience at Applied Biosystems and Celera. Before being named Vice President of Advanced Research and Technology, he held the positions of Vice President, Genomics Applications, Applied Biosystems and Vice President, Gene Discovery, Celera. Prior to joining Applied Biosystems as a research scientist, he was Program Manager, Genetics at W.R. Grace. Dr. Gilbert received a bachelor of science in biochemistry and cell biology from the University of California, San Diego, and his Ph.D. in genetics from Johns Hopkins University, followed by postdoctoral training in population genetics at the National Cancer Institute.
| Organization | Position | Status |
|---|---|---|
| Vitapath Genetics, Inc. | Chief Scientific Officer | Current |
| Vitapath Genetics, Inc. | Founder | Current |
| Applied Biosystems Group | Current | |
| Applera Corporation | Chief Scientific Officer | Former |
| Applera Corporation | Vice President | Former |
| W.R. Grace & Company | Program Manager | Former |
| Applera Corporation | Research Scientist | Former |
| The Johns Hopkins University | PH.D. In Genetics | Former |
| University of California, San Diego | Bachelor of Science In Biochemistry and Cell Biology | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Senior Staff Scientist | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Current |
Mr. Tobin has served as President and Chief Executive Officer of Boston Scientific Corporation, a medical device manufacturer, since March 1999. Mr. Tobin previously served as President and Chief Executive Officer of Biogen, Inc., a biotechnology company, from 1997 to 1998 and President and Chief Operating Officer from 1994 to 1997. Prior to joining Biogen, he held various positions at Baxter International Inc., including President and Chief Operating Officer from 1992 to 1994. Mr. Tobin is also a director of Boston Scientific and Curis, Inc.
| Organization | Position | Status |
|---|---|---|
| Celera Genomics | Current | |
| Applied Biosystems Group | Co-Chair | Current |
| Applera Corporation | Board Member | Current |
| Curis, Inc. | Board of Directors | Current |
| Beth Israel Deaconess Medical Center | Board Member | Current |
| Biogen Idec, Inc. | Chief Executive Officer | Former |
| Biogen, Inc. | Chief Executive Officer | Former |
| Boston Scientific Corporation | President & Chief Executive Officer | Former |
| Biogen Idec, Inc. | President | Former |
| Biogen, Inc. | President | Former |
| Baxter International Inc. | President | Former |
| Curis, Inc. | President | Former |
| Biogen Idec, Inc. | Chief Operating Officer | Former |
| Baxter International Inc. | Chief Operating Officer | Former |
| Biogen, Inc. | Chief Operating Officer | Former |
| Baxter International Inc. | Executive Vice President | Former |
| Baxter International Inc. | Managing Director | Former |
| Guidant Corporation | Director, President & CEO | Former |
| U.S. Navy | Lieutenant | Former |
| Baxter International Inc. | NA | Former |
| Curis, Inc. | Chair | Former |
| Creative BioMolecules, Inc. | Board of Directors | Former |
| Boston Scientific Corporation | Board of Directors | Former |
| Biogen, Inc. | Director | Former |
| Applied Biosystems Group | Board of Directors | Former |
| Harvard Business School | M.B.A | Former |
| Harvard College | A.B | Former |
| Organization | Position | Status |
|---|---|---|
| Harvard Business School | Professor of Business Administration | Current |
| Celera Genomics | Current | |
| Celera Diagnostics, LLC | Current | |
| Applied Biosystems Group | Co-Chair | Current |
| Applera Corporation | Director | Current |
| Helix Technology Corporation | Director | Current |
| Applied Biosystems Group | Committee Member | Current |
| Harvard Business School | Director | Former |
| Harvard Business School | Business Administration | Former |
Arnold J. Levine, Ph.D., is a Professor at The Cancer Institute of New Jersey, Robert Wood Johnson School of Medicine and a Professor at the Institute for Advanced Study. From 1998 - 2002, Dr. Levine was President of Rockefeller University. Prior to joining Rockefeller University, Dr. Levine was the Harry C. Weiss Professor in the Life Sciences and Chairman of the Department of Molecular Biology at Princeton University from 1984 - 1996. Dr. Levine also serves as a Director of Theravance, Inc. and Applera Corporation, publicly traded life science companies. Dr. Levine received a B.A. in Biology from Harpur College, State University of New York at Binghamton and a Ph.D. in Microbiology from the University of Pennsylvania.
| Organization | Position | Status |
|---|---|---|
| Infinity Pharmaceuticals, Inc | Lead Research & Development Director | Current |
| Cancer Institute | Prof | Current |
| Institute for Advanced Studies | Visiting Professor | Current |
| The Cancer Institute of New Jersey | Professor | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Bg Medicine, Inc. | Co-Chairman | Current |
| Theravance, Inc. | Chairperson | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Exsar Corporation | Board of Directors | Current |
| National Academy of Sciences | Board of Directors | Current |
| Avidimer Therapeutics, Inc. | Board of Directors | Current |
| Theravance, Inc. | Board of Directors | Current |
| The Ellison Medical Foundation | Board of Directors | Current |
| Functional Genetics, Inc. | Board of Directors | Current |
| Infinity Pharmaceuticals, Inc | Board of Directors | Current |
| Applera Corporation | Director | Current |
| Theravance, Inc. | Committee Member | Current |
| The Rockefeller University | Chief Executive Officer | Former |
| The Rockefeller University | President | Former |
| Princeton University | Professor | Former |
| The Rockefeller University | Visiting Professor | Former |
| Princeton University | Chairman | Former |
| University of Pennsylvania | Ph.D. In Microbiology | Former |
| University of Pennsylvania School of Medicine | PhD In Microbiology | Former |
| State University of New York at Binghamton | B.A. | Former |
| National Academy of Sciences | member | Former |
| United States Public Health Services (USPHS) | Fellow | Former |
Dr. Slayman is the Sterling Professor of Genetics and Deputy Dean for Academic and Scientific Affairs at Yale University School of Medicine. She joined the Yale faculty in 1967. Dr. Slayman is a consultant to the National Institutes of Health, most recently having served as a member of the National Advisory General Medical Sciences Council, and a member of the Board of Overseers of Dartmouth Medical School.
| Organization | Position | Status |
|---|---|---|
| Genetics, Inc. | Sterling Professor | Current |
| Yale University School of Medicine | Deputy Dean | Current |
| National Institutes of Health | Consultant | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Applied Biosystems Group | Board of Directors | Current |
| Applera Corporation | Director | Current |
| Progress Daily | Committee Member | Current |
| Flandersbio | Committee Member | Current |
| Olink | Committee Member | Current |
| Applied Biosystems Group | Committee Member | Current |
| Yale University | Deputy Dean for Academic and Scientific Affairs | Former |
| Dartmouth Medical School | member | Former |
| Organization | Position | Status |
|---|---|---|
| Washington University School of Medicine | Assistant Professor of Genetics | Current |
| Progress Daily | Board of Directors | Current |
| Flandersbio | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Orion Genomics, LLC | Board of Directors | Current |
| The University of Oklahoma | Ph.D. In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
| Applied Biosystems Group | Committee Member | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | board member | Current |
| Applied Biosystems Group | Division President, Proteomics and Small Molecule Division | Former |
| Applied Biosystems Group | Product Manager | Former |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Board of Directors | Current |
Mr. Ayers is the retired Chairman and Chief Executive Officer of The Stanley Works, a tool and hardware manufacturer. He was an advisor to the Chairman and Chief Executive Officer of Stanley from January 1997 to October 1997 after having served as Chairman and Chief Executive Officer of Stanley from May 1989 to December 1996. Mr. Ayers is a Trustee of MassMutual Institutional Funds and MML Series Investment Fund and a director of Instron Corporation.
| Organization | Position | Status |
|---|---|---|
| Applera Corporation | Committee Member | Current |
| Celera Diagnostics, LLC | Current | |
| The Stanley Works | Chairman | Current |
| Instron Corporation | Director | Current |
| Applera Corporation | Director | Current |
| Celera Genomics | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Applied Biosystems Group | Committee Member | Current |
| Olink | Committee Member | Current |
| The Stanley Works | Chief Executive Officer | Former |
| Organization | Position | Status |
|---|---|---|
| Barnes Group Inc. | Chief Executive Officer | Current |
| Barnes Group Inc. | President | Current |
| Barnes Group Inc. | Group Vice President | Current |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Ingersoll-Rand Company Limited | Board of Directors | Current |
| C.R. Bard, Inc. | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Applera Corporation | Board of Directors | Current |
| Barnes Group Inc. | Director | Former |
Array
| Organization | Position | Status |
|---|---|---|
| NYSE Group, Inc. | Current | |
| Celera Diagnostics, LLC | Current | |
| Celera Genomics | Current | |
| Rozynski & Associates | Current | |
| Resgen Inc. | Board of Directors | Current |
| Pittsburgh Tissue Engineering Initiative, Inc | Board of Directors | Current |
| Olink | Board of Directors | Current |
| Ionsource, LLC | Board of Directors | Current |
| IDEXX Laboratories, Inc. | Board of Directors | Current |
| Industry Ventures | Board of Directors | Current |
| HCR ManorCare, Inc. | Board of Directors | Current |
| Applied Biosystems Group | Board of Directors | Current |
| Horizon Health Corporation | Director | Current |
| West Pharmaceutical Services, Inc. | Director | Current |
| Applera Corporation | Director | Current |
| C.R. Bard, Inc. | Director | Current |
| Microseq | Board of Directors | Current |
| Biolayer Corporation Limited | Board of Directors | Current |
| Centenary College | Trustee | Current |
| Healthios Group, LLC | Member | Current |
| C.R. Bard, Inc. | President | Former |
| Lifemark | Officer | Former |
| American Hospital Supply Corporation | Former | |
| Lifemark | Director | Former |
| Northwestern University | Graduate Degree In Management | Former |
| Drake University | Bachelor's Degrees In Business Administration | Former |
| Organization | Position | Status |
|---|---|---|
| International Venture Partners, Inc. | General Partner | Current |
| Cortina Systems Corporation | Board of Directors | Current |
| Genentech, Inc. | Venture Investor | Current |
| Verisity, Ltd. | Venture Investor | Current |
| Aspect Software, Inc. | Investor | Current |
| 3Com Corporation | Venture Investor | Current |
| Cypress Semiconductor Corporation | Venture Investor | Current |
| Silicon Graphics, Inc. | Venture Investor | Current |
| Artisan Components, Inc. | Investor | Current |
| WebEx Communications, Inc. | Venture Investor | Current |
| MIPS Technologies, Inc. | Venture Investor | Current |
| LSI Corporation | Venture Investor | Current |
| Applied Biosystems Group | Venture Investor | Current |
| Dust Networks | Venture Investor | Current |
| Linear Technology Corp. | Venture Investor | Current |
| SupportSoft, Inc. | Venture Investor | Current |
| Concur Technologies, Inc. | Investor | Current |
| Compaq Computers | Investor | Current |
| Websense Inc. | Investor | Current |
| Lam Research Corporation | Investor | Current |
| Polycom, Inc. | Investor | Current |
| Motion Computing, Inc. | Investor | Current |
| @Road, Inc. | Venture Investor | Current |
| Amgen Inc. | Venture Investor | Current |
| Quantum Corporation | Venture Investor | Current |
| Digital River, Inc. | Venture Investor | Current |
| Institutional Venture Partners | General Partner | Former |
| Hewlett-Packard Company | computer programmer | Former |
| McKinsey & Company, Inc. | management consultant | Former |
| Stanford University | Board Member | Former |
| Harvard Law School | J.D | Former |
| Harvard Business School | M.B.A | Former |
| Stanford University | B.S. degree in Management Science & Engineering | Former |
Executive News
-
Strategic Product Development Expert to Educate Utah Technology Company Executives
-
UPDATE 1-Leerink Swann raises Boston Scientific to outperform
Industry Transcripts by Seeking Alpha
-
Deere & Company F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 25, 2009about DE
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
Glass Door
Applied Biosystems
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- E-Book Publisher Smashwords Partners with Barnes & Noble 6 votes
